The Route Less Travelled
Pharmaron has over 35 years of experience in preclinical drug delivery services, with expertise across a range of dose routes (i.e., ocular, buccal, vaginal, dermal, transdermal, nasal, etc.), disease models and pharmacological endpoints.
Find out more about the importance of preclinical models in the evaluation of novel drug delivery systems, including toxicology, pharmacokinetics and dynamics, and patient considerations. In this whitepaper, we highlight the need to match preclinical development strategy with the right model systems, from in vitro assays to in vivo animal models of specific disease states.
To learn more, please complete the form below to download this whitepaper: The Route Less Travelled